These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19074551)

  • 1. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.
    Ma Q; Fu W; Li P; Nicosia SV; Jenster G; Zhang X; Bai W
    Mol Endocrinol; 2009 Feb; 23(2):213-25. PubMed ID: 19074551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
    Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
    Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
    Liu P; Li S; Gan L; Kao TP; Huang H
    Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.
    Mediwala SN; Sun H; Szafran AT; Hartig SM; Sonpavde G; Hayes TG; Thiagarajan P; Mancini MA; Marcelli M
    Prostate; 2013 Feb; 73(3):267-77. PubMed ID: 22821817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
    Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
    Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
    Gan L; Chen S; Wang Y; Watahiki A; Bohrer L; Sun Z; Wang Y; Huang H
    Cancer Res; 2009 Nov; 69(21):8386-94. PubMed ID: 19826044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
    Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
    J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
    Li P; Lee H; Guo S; Unterman TG; Jenster G; Bai W
    Mol Cell Biol; 2003 Jan; 23(1):104-18. PubMed ID: 12482965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.
    Zhao Y; Tindall DJ; Huang H
    Int J Biol Sci; 2014; 10(6):614-9. PubMed ID: 24948874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
    Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
    Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer.
    Wang Y; He X; Ngeow J; Eng C
    Hum Mol Genet; 2012 Feb; 21(3):569-76. PubMed ID: 22021428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
    Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
    Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity.
    Nan B; Snabboon T; Unni E; X-J Yuan ; Whang YE; Marcelli M
    J Mol Endocrinol; 2003 Aug; 31(1):169-83. PubMed ID: 12914534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
    Ikonen T; Palvimo JJ; Jänne OA
    J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.
    Li H; Mohamed AA; Sharad S; Umeda E; Song Y; Young D; Petrovics G; McLeod DG; Sesterhenn IA; Sreenath T; Dobi A; Srivastava S
    Oncotarget; 2015 Jun; 6(17):15137-49. PubMed ID: 25883222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src.
    Sun M; Yang L; Feldman RI; Sun XM; Bhalla KN; Jove R; Nicosia SV; Cheng JQ
    J Biol Chem; 2003 Oct; 278(44):42992-3000. PubMed ID: 12933816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.